feed,title,long_url,short_url
FDA:MedWatch,IBSA Pharma Inc. Issues Voluntary Nationwide Recall of Select Lots of TIROSINTÂ®-SOL (levothyroxine sodium) Oral Solution Due to Subpotency,http://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/ibsa-pharma-inc-issues-voluntary-nationwide-recall-select-lots-tirosintr-sol-levothyroxine-sodium,https://da.gd/5tE4J
